Blue Crest Capital Management LTD Senseonics Holdings, Inc. Transaction History

Blue Crest Capital Management LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$2.3 - $3.27 $26,114 - $37,127	-11,354 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$2.49 - $4.54 $28,271 - $51,547	11,354 New	11,354 $29,000
Q2 2018 Aug 14, 2018	SELL	$3.03 - $4.98 $527,041 - $866,226	-173,941 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$2.48 - $3.21 $247,129 - $319,873	99,649 Added 134.13%	173,941 $522,000
Q4 2017 Feb 14, 2018	BUY	$2.43 - $3.54 $180,529 - $262,993	74,292	74,292 $198,000

141

66.5M

505K

209K

Ticker SENS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 465,447,008
Market Cap $610M
Description
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

Stay updated on Blue Crest Capital Management LTD with notifications on news.